Tu1750 RESPONSE TO ETRASIMOD TREATMENT IN ULCERATIVE COLITIS IS ASSOCIATED WITH A REDUCTION OF CIRCULATING B- AND PRO-INFLAMMATORY T CELLS: A SINGLE-CELL-BASED POST-HOC SUBANALYSIS OF THE ELEVATE UC 52 TRIAL